Meeting
2022 ASCO Annual Meeting
Comparison of four clinical prognostic scores in patients with advanced gastric and esophageal cancer.
Authors
Lucy Xiaolu Ma
Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada
Lucy Xiaolu Ma , Osvaldo Espin-Garcia , Yvonne Bach , Hiroko Aoyama , Michael J Allen , Xin Wang , Gail Elizabeth Darling , Jonathan Yeung , Carol Jane Swallow , Savtaj Singh Brar , Patrick Veit-Haibach , Sangeetha Kalimuthu , Rebecca KS Wong , Eric Xueyu Chen , Grainne M. O'Kane , Raymond Woo-Jun Jang , Elena Elimova
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4057)
DOI
10.1200/JCO.2022.40.16_suppl.4057
Abstract #
4057
Poster Bd #
45
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Prognostic significance of nutritional risk index in patients with metastatic esophageal squamous cell cancer.
First Author: Hiromichi Shirasu
Poster
2018 Gastrointestinal Cancers Symposium
Outcomes for advanced HER2-positive gastroesophageal cancer by anatomical location: Experience from the Princess Margaret Cancer Centre.
First Author: Charles Henry Lim
Poster
2017 Gastrointestinal Cancers Symposium
Nab-paclitaxel and gemcitabine in advanced pancreatic cancer: The one-year experience of the National Cancer Institute of Naples.
First Author: Alessandro Ottaiano
Poster
2013 Gastrointestinal Cancers Symposium
Single-center experience with paclitaxel (T), carboplatin (C), and capecitabine (X) in the treatment of advanced esophagogastric cancer.
First Author: Carl Ruoff